Company
ImmunitasTx
Founded to discover and develop novel, differentiated therapeutics for cancer and autoimmune diseases.
Also known as Immunitas, Immunitas Therapeutics, Immunitas Therapeutics, Inc.
- Status
- Operatingas of 2026-09-23
- Business model
- B2B
- Headquarters
- Boston, MA, United States
- Legal name
- Immunitas Therapeutics, Inc.
Claim, correct or request removal
Record updated 28 September 2026
About
Immunitas was founded to discover and develop novel, differentiated therapeutics for patients with cancer and autoimmune diseases.
Funding snapshot
- Total raised
- $58MSum of rounds, as of 2026-09-17Source (opens in a new tab)
- Latest round
- Series B, $58M2021-08-18
Funding rounds
- Series B
- $58M2021-08-18, Company stated
- Round, 2021
- $29.1M2021-08-10, SEC form D sold, 21 investors
Products
- Web
- IMT-009
- Web
- IMT-380
Loading relationship preview